Tuesday 13 October 2026 Export SLSN’s income statement to Excel — free account

Solesence, Inc.

SLSN Consumer Defensive Household & Personal Products

Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 24.7%, EPS fell 105.5%, free cash flow grew 86.5% and total debt rose 36.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.02 0.00 0.00%

Follow SLSN

Alert me

Market cap: $70.7M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: 2/9
Altman Z: 1.02
Beneish M: −1.13
Dividend safety: n/a

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 0.07

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	1	1	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 74.05%

Capital & Financial Ratios $m

Market Cap 70.65

Revenue 55.37

Net Income (2.91)

Free Cash Flow (0.85)

Net Debt 13.24

Current Ratio 0.97

Debt/Equity 1.09

P/E ratio 0.00

Fwd P/E —

P/S ratio 1.30

P/B ratio 5.48

Past 5Y EPS Growth (7.79%)

This Y EPS Growth —

Next Y EPS Growth —

Next Y revenue growth —

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 26.25%

10-year low 10-year high

P/B against its own 10 years 11.74%

10-year low 10-year high

EV/Sales against its own 10 years 44.44%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	2	1	1	1
Receivables	3	5	7	9
Inventory	10	20	19	13
Other	—	—	—	—
	16	29	29	25

	2023	2024	2025	Q'26
Payables	6	9	4	5
ST’ Debt	5	5	5	14
Other	—	—	—	—
	16	26	14	26

Compound Annual Growth %

	10y	5y	3y
Sales	19.66%	29.38%	18.48%
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	12.60%	0.00%
Book Value	19.95%	45.20%	46.15%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	13	15	—	—	—
’25	15	20	15	12	62
’24	10	13	17	13	52
’23	9	12	8	8	37
’22	8	11	10	8	37
’21	7	7	8	7	29
’20	4	4	4	5	17

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	2	0	—	—	—
’25	(7)	(1)	(3)	2	(9)
’24	(4)	(1)	4	2	2
’23	(1)	(1)	3	(3)	(2)
’22	(2)	(2)	1	1	(2)
’21	0	1	0	2	2
’20	(1)	0	0	0	(2)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	1	0	—	—	—
’25	(7)	(2)	(3)	1	(11)
’24	(4)	(1)	3	0	(3)
’23	(1)	(2)	3	(3)	(3)
’22	(2)	(2)	0	0	(4)
’21	0	0	(1)	2	0
’20	(1)	0	(1)	(1)	(3)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.01)	0.00	—	—	—
’25	0.00	0.04	(0.02)	(0.01)	0.02
’24	0.02	0.01	0.04	(0.01)	0.07
’23	(0.02)	0.01	(0.03)	(0.04)	(0.09)
’22	0.00	0.00	(0.02)	(0.04)	(0.05)
’21	0.03	0.00	0.03	(0.01)	0.05
’20	0.00	0.01	0.01	0.00	0.03

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	0.37	0.36	0.40	0.25	0.17	0.74	1.09	0.32	0.40	1.34	Analyst estimates 2026–2028 Powerpack
	High	0.87	0.78	1.34	0.80	0.95	4.45	4.44	1.80	2.91	16.56
People
People	Employees	46	48	54	53	54	58	82	79	98	115
	Revenue/emp, $m	0.23	0.26	0.26	0.24	0.32	0.51	0.46	0.47	0.53	0.54
Income, $m
Income, $m	Revenue	11	12	14	13	17	29	37	37	52	62
	Gross margin, %	30.05	30.87	23.18	20.91	34.98	29.48	22.40	20.98	30.92	25.88
	EBT	(1)	(1)	(2)	(3)	1	2	(3)	(4)	4	2
	EBT margin, %	(11.90)	(6.33)	(14.66)	(24.03)	5.78	8.00	(7.07)	(11.75)	8.52	3.00
	Net income	(1)	(1)	(2)	(3)	1	2	(3)	(4)	4	2
	Depreciation	1	0	0	0	1	1	1	1	1	1
Per share, $
Per share, $	Revenue	0.35	0.40	0.42	0.34	0.45	0.65	0.76	0.75	0.84	0.88
	Earnings	(0.04)	(0.03)	(0.06)	(0.08)	0.03	0.05	(0.05)	(0.09)	0.07	0.03
	Cash flow	(0.01)	(0.03)	(0.04)	(0.08)	(0.05)	0.05	(0.03)	(0.04)	0.03	(0.12)
	Capex	(0.01)	0.00	0.00	(0.02)	(0.02)	(0.04)	(0.06)	(0.02)	(0.07)	(0.03)
	Free cash flow	(0.01)	(0.03)	(0.04)	(0.10)	(0.08)	0.01	(0.09)	(0.06)	(0.04)	(0.15)
	Book value	0.09	0.10	0.04	0.04	0.07	0.17	0.12	0.04	0.24	0.25
	Shares, m	31	31	34	37	38	45	49	50	62	70
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	34.55	79.71	0.00	0.00	37.48	82.90
	P/S	2.06	1.31	1.74	0.82	1.89	6.72	1.49	0.80	2.91	1.81
	P/B	7.97	5.04	17.87	6.78	11.87	26.54	9.83	15.63	10.18	7.99
	EV/Sales	1.93	1.20	1.73	0.85	1.99	6.77	1.65	1.04	3.09	2.04
	EV/FCF	(51.20)	(14.49)	(16.37)	(3.03)	(11.62)	446.18	(13.77)	(12.70)	(62.59)	(11.81)
Cash, $m
Cash, $m	Operating cash flow	0	(1)	(1)	(3)	(2)	2	(2)	(2)	2	(9)
	Capex	0	0	0	(1)	(1)	(2)	(3)	(1)	(5)	(2)
	Free cash flow	0	(1)	(2)	(4)	(3)	0	(4)	(3)	(3)	(11)
Balance, $m
Balance, $m	Working capital	2	3	1	1	2	4	3	1	4	15
	Total debt	0	0	1	2	3	1	8	11	5	15
	Net debt	(2)	(2)	0	0	2	0	6	9	4	14
	Shareholders’ equity	3	3	1	2	3	7	6	2	15	18
Returns, %
Returns, %	ROA	(27.25)	(14.21)	(32.43)	(37.71)	8.63	11.07	(8.47)	(13.22)	10.22	3.58
	ROIC	(70.63)	(28.50)	(120.99)	(90.31)	20.93	20.47	(12.02)	(20.17)	17.30	3.11
	ROE	(45.40)	(26.20)	(90.16)	(207.67)	46.62	45.50	(40.00)	(116.28)	50.27	10.99

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
ACU Acme United Corporation.	$238.3M	24.2×	31.0×	+16.15% (above 0%: growing)	+4.76% (above 0%: growing)	+155.61% (above 0%: growing)	42.55%	10.89%	Compare
NUS Nu Skin Enterprises, Inc.	$230.7M	— (loss-making)	5.9×	−17.10% (below 0%: shrinking)	n/m	−86.06% (below 0%: shrinking)	68.20%	(18.53%)	Compare
YSG Yatsen Holding Limited Sponsored ADR	$164.5M	— (loss-making)	32.2×	+10.97% (above 0%: growing)	n/m	+14.56% (above 0%: growing)	73.88%	(11.55%)	Compare
MLKMF Waldencast PLC	$111.9M	— (loss-making)	— (loss-making)	—	n/m	−345.38% (below 0%: shrinking)	46.91%	0.00%	Compare
SLSN Solesence, Inc.	$72.1M	— (loss-making)	—	−24.69% (below 0%: shrinking)	n/m	+86.52% (above 0%: growing)	30.97%	0.79%
SKIN SkinHealth Systems Inc.	$71.6M	— (loss-making)	— (loss-making)	−7.77% (below 0%: shrinking)	n/m	−81.89% (below 0%: shrinking)	68.42%	4.95%	Compare
GROV Grove Collaborative Holdings, Inc.	$44.4M	— (loss-making)	— (loss-making)	−16.94% (below 0%: shrinking)	n/m	+101.08% (above 0%: growing)	53.56%	(2.14%)	Compare
UG United-Guardian, Inc.	$32.2M	12.8×	18.7×	+9.52% (above 0%: growing)	+14.29% (above 0%: growing)	+428.43% (above 0%: growing)	49.73%	24.26%	Compare
DSY Big Tree Cloud Holdings Limited	$28.7M	18.7×	—	—	0.00%	−267.22% (below 0%: shrinking)	—	—	Compare
Median of peers	$91.7M	18.7×	24.9×	+0.88%	+4.76%	−33.66%	53.56%	0.00%

All 32 Household & Personal Products stocks →

Solesence, Inc. (SLSN) key facts

Strength: Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024.
Solesence, Inc. (SLSN) is a Household & Personal Products company in the Consumer Defensive sector, listed on Nasdaq.
As of October 12, 2026, SLSN traded at $1.02, a market capitalization of $70.7 million.
Return on equity was 11.0% and debt-to-equity 1.09.
Its Piotroski F-score is 2 out of 9 and its Altman Z-score is 1.02 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.